tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Summit Therapeutics reports Q4 adjusted EPS (14c), consensus (1c)
PremiumThe FlySummit Therapeutics reports Q4 adjusted EPS (14c), consensus (1c)
28d ago
Summit Therapeutics options imply 6.1% move in share price post-earnings
Premium
The Fly
Summit Therapeutics options imply 6.1% move in share price post-earnings
28d ago
SMMT Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SMMT Upcoming Earnings Report: What to Expect?
1M ago
Summit Therapeutics Advances Ivonescimab Into Key Phase 3 Test in Metastatic Colorectal Cancer
PremiumCompany AnnouncementsSummit Therapeutics Advances Ivonescimab Into Key Phase 3 Test in Metastatic Colorectal Cancer
2M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
Summit Therapeutics: Ivonescimab OS Readout, Regulatory Milestones, and GSK Partnership Underpin Reaffirmed Buy and $40 Target
Premium
Ratings
Summit Therapeutics: Ivonescimab OS Readout, Regulatory Milestones, and GSK Partnership Underpin Reaffirmed Buy and $40 Target
2M ago
Summit Therapeutics reports inducement grants under Nasdaq listing rule
PremiumThe FlySummit Therapeutics reports inducement grants under Nasdaq listing rule
2M ago
Summit Therapeutics upgraded to Equal Weight from Underweight at Barclays
Premium
The Fly
Summit Therapeutics upgraded to Equal Weight from Underweight at Barclays
3M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100